The Asia Pacific smart inhalers market is expected to reach US$ 1,539.97 Mn in 2027 from US$ 186.63 Mn in 2018. The market is estimated to grow with a CAGR of 27.2% from 2019-2027. The growth of the smart inhalers market is primarily attributed to the growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition as well as the presence of supportive associations in the region.However, risks associated with cyber threats with smart inhalers are likely to pose a negative impact on market growth.
On the other hand, the development of growth in the Asia pacific healthcare market is likely to have a positive impact on the growth of the Europe smart inhalers market in the coming years. With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the Asia Pacific. Some of the factors leading to growth in the number of asthma and COPD cases across the Asia Pacific are a rise in air pollution levels and increasing smoking habits. The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies.As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants.
Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into the lungs and the cardiovascular system.This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others.
In 2016 Among the 2.2 million air pollution-related deaths in Asia pacific region, 29% were due to heart disease, 27% stroke, 22% chronic obstructive pulmonary disease, 14% lung cancer and 8% pneumonia. Additionally increasing indirect effects of air pollution like growing climate change, because of transport is the fastest growing source of fossil-fuel emissions of carbon dioxide (CO2) which is a most significant contributor of climate change. In 2017 World Health Organization (WHO) held a member states consultation on addressing the health impact of air pollution in the western pacific region, and continues to take steps to improve the situation. Children living near roads with heavy-duty vehicle traffic have twice the risk of respiratory problems as those living near less congested streets. Hence, the rising levels of air pollution coupled are anticipated to drive the demand for the smart inhalers market during the forecast period. In 2018, the inhalers segment held a largest market share of the smart inhalers market, by product.The inhalers is expected to dominate its market share in 2027 owing to the increasing mortality rate of asthma.
The inhalers segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027. Home-care setting segment a largest market share of the smart inhalers market, by end user in 2018.This segment is also expected to dominate the market in 2027.
As smart inhaler devices are connected digitally, enabling the patients to get advice from their physicians, even when situated far away. Home-care setting segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027. Some of the major primary and secondary sources for smart inhalers included in the report are, GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AG, Findair Sp. z o. o., Cohero Health, Crux Product Design Ltd, Teva Pharmaceuticals, 3M, Amiko Digital Health Limited, and others.
Our reports have been used by over 10K customers, including:
236 pages •
By The Business Research Company
• Feb 2022
Nebulizers Global Market Opportunities And Strategies To 2030: COVID 19 Implications And Growth provides the strategists; marketers and senior management with the critical information they need to assess the global nebulizers market as it emerges from the COVID 19 shut down. Description: Where is the largest and...
The respiratory care devices market is expected to reach USD 27.6 billion by 2026 from USD 18.4 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026. Due to the outbreak of corona virus globally, there is a sudden rise in the demand for respiratory care devices. The major factor driving the growth of the respiratory...
The sleep apnea devices market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period. Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral...
Scope of the Report The report titled “Global Respiratory Care Medical Devices Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in-depth analysis of the global respiratory care medical devices market with description of market sizing and growth. The analysis includes market by value and market share by...
The respiratory ventilator tester market was valued at US$ 148.00 million in 2019 and is projected to reach US$ 199.20 million by 2027; it is expected to grow at a CAGR of 3.8% from 2020 to 2027. The growth of the market is mainly attributed to factors such as growing prevalence of respiratory diseases and increasing geriatric population....
The global respiratory care devices market is expected to reach nearly US$ 35 Billion by 2026. Respiratory care is a healthcare specialty, which is focused on improving cardiopulmonary functions and promoting health & wellness. Respiratory care devices are used for the diagnosis, treatment, and monitoring of patients who are suffering from...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Respiratory Inhalers Market Report The respiratory inhalers market by revenue is expected to grow at a CAGR of over 9% during the period 2019–2025. The global respiratory inhalers market is one of the steadily growing segments in...
Executive Summary The Global Oxygen Concentrator Market was valued at USD 1784.66 Million in the year 2019. Escalating number of cases related to Respiratory and Lungs Diseases with growing prevalence of COPD, Strokes supported by ever growing geriatric population and companies making huge investments in incorporating advanced...
The pulmonary devicesmarket was valued at US$ 18,598.56 million in 2019 and is projected to reach US$ 39,965.01 million by 2027; it is expected to grow at a CAGR of 10.1%from 2020 to 2027. Rising number of COVID-19 cases worldwide and increasing prevalence of respiratory diseasesare the key factors fueling the market growth. Moreover, strategic...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Nebulizer Market Report The nebulizer market by revenue is expected to grow at a CAGR of over 7% during the period 2019–2025. The global nebulizer market is one of the steady growing segments in the global medical devices market. It is...
Respiratory Device
World
Asthma Prevalence
Chronic Obstructive Pulmonary Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.